Date of Testing

6 May 2016

Objective

This study evaluated the PRP products from five centrifuged-based platforms: GS30- PurePRP® II and GS60-PurePRP® II, (EmCyte Corporation®), MAGELLAN, (Arteriocyte), REGENKIT®-THT (Stryker) and, ECLIPSE PRP (ECLIPSE Aesthetics) in a paired assay design with all five platforms tested with each donor.